Document is current
Any future updates will be listed below
-
Authors
Drake, Lara https://orcid.org/0000-0003-3107-6246
Reyes-Hadsall, Sophia https://orcid.org/0000-0002-1580-8008
Barbieri, John S. https://orcid.org/0000-0002-5467-4102
Mostaghimi, Arash https://orcid.org/0000-0002-6084-5617
- License Information
-
More Information
Article History
Accepted: 6 December 2021
First Online: 18 January 2022
Declarations
:
: No sources of funding were used to conduct this study or prepare this manuscript.
: Lara Drake, Sophia Reyes-Hadsall, and John S Barbieri have no conflicts of interest that are directly relevant to the content of this article. Dr. Mostaghimi has received royalty payments from Pfizer for licensing of the ALTO tool; has participated in clinical trials related to alopecia by Incyte, Lilly, Concert, and Aclaris; and has received consulting fees from Pfizer.
: Not applicable.
: Not applicable.
: Not applicable.
: All authors contributed to the study conception and design. Lara Drake and Sophia Reyes-Hadsall conducted the literature search and data analysis and wrote the first draft of the manuscript. All authors commented on subsequent versions of the manuscript and read and approved the final manuscript.
